Abiopharma

(80% Positive) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K)

(99% Neutral) VERTEX PHARMACEUTICALS INC / MA (VRTX) Announces Business Combination

(99% Neutral) Ascendis Pharma (ASND) Announces Clinical Development Update (Form 6-K)

(10% Negative) RAPT Therapeutics, Inc. (RAPT) Announces Delay in trial Trials for atopic dermatitis Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(10% Negative) Seagen Inc. (SGEN) Announces Delay in release Trials for its territory Due to Regulatory Process, Safety Review, Efficacy Assessment

(10% Negative) INSMED INCORPORATED (INSM) Announces Delay in point Trials for launching new product Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(19% Negative) Cellectis (CLLS) Announces 2022 Annual General Meeting

(75% Positive) ImmunoGen, Inc. (IMGN) Announces Clinical Development Update

(99% Neutral) COHERUS BIOSCIENCES, INC. (CHRS) Announces Regulatory Update

(99% Neutral) Instil Bio, Inc. (TIL) Announces Regulatory Update